Oxbryta vs. Endari

Reviewed on 1/26/2021

Are Oxbryta and Endari the Same Thing?

Oxbryta (voxelotor) and Endari (L-glutamine oral powder) are used to treat sickle cell disease.

Oxbryta is used to treat sickle cell disease in adults and pediatric patients 12 years of age and older and Endari is used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.

Oxbryta and Endari belong to different drug classes. Oxbryta is a hemoglobin S polymerization inhibitor and Endari is an amino acid.

Side effects of Oxbryta and Endari that are similar include headache, nausea, and stomach/abdominal pain.

Side effects of Oxbryta that are different from Endari include diarrhea, tiredness/fatigue, rash, and fever.

Side effects of Endari that are different from Oxbryta include constipation, cough, pain in extremities, back pain, chest pain, indigestion, burning sensation, and hot flashes.

Oxbryta may interact with strong CYP3A4 inhibitors, fluconazole, strong or moderate CYP3A4 inducers, and midazolam.

Endari may interact with other drugs.

What Are Possible Side Effects of Oxbryta?

Common side effects of Oxbryta include:

  • headache,
  • diarrhea,
  • stomach/abdominal pain,
  • nausea,
  • tiredness/fatigue,
  • rash, and
  • fever

What Are Possible Side Effects of Endari?

Common side effects of Endari include:

  • constipation,
  • nausea,
  • headache,
  • abdominal pain,
  • cough,
  • pain in extremities,
  • back pain,
  • chest pain,
  • indigestion,
  • burning sensation, and
  • hot flashes

QUESTION

What is hemophilia? See Answer

What Is Oxbryta?

Oxbryta (voxelotor) is a hemoglobin S polymerization inhibitor used to treat sickle cell disease in adults and pediatric patients 12 years of age and older.

What Is Endari?

Endari (L-glutamine oral powder) is an amino acid indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.

What Drugs Interact With Oxbryta?

Oxbryta may interact with other medicines such as:

  • strong CYP3A4 inhibitors,
  • fluconazole,
  • strong or moderate CYP3A4 inducers, and
  • midazolam

Tell your doctor all medications and supplements you use.

What Drugs Interact With Endari?

Endari may interact with other drugs. Tell your doctor all medications and supplements you use.

How Should Oxbryta be Taken?

The recommended dosage of Oxbryta is 1,500 mg orally once daily with or without food.

How Should Endari be Taken?

The dose of Endari is 5 to 15 grams orally, twice daily based on body weight. Each dose of Endari should be mixed in 8 oz. (240 mL) of cold or room temperature beverage or 4 to 6 oz. of food before ingestion.

SLIDESHOW

Anemia Symptoms and Signs, Types, Treatment and Causes See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Global Blood Therapeutics, Inc. Oxbryta Product Information.

https://oxbryta.com/

Emmaus Medical. Endari Product Information.

https://www.endarirx.com/

Health Solutions From Our Sponsors